The novel third-generation antipsychotic drug brexpiprazole affects hepatic transcription factors, serum hormone levels, and cytochrome P450 enzymes after prolonged treatment: pharmacological significance
Przemysław J Danek, Renata Pukło, Władysława A Daniel · 2026
Read The novel third-generation antipsychotic drug brexpiprazole affects hepatic transcription factors, serum hormone levels, and cytochrome P450 enzymes after prolonged treatment: pharmacological significance by Przemysław J Danek, Renata Pukło, Władysława A Daniel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13275521.txt.
Description
Przemyslaw Danek, Renata Puklo, and Wladyslawa Daniel study in 2026 how a newer antipsychotic drug affects liver enzymes in rats after long treatment. The drug, brexpiprazole, treats schizophrenia and related disorders. Since many other drugs pass through the same liver enzymes, interactions are a concern.
Male rats received the drug for two weeks, then liver and blood were tested. The drug raised activity of several enzyme types and lowered others. Changes matched shifts in liver transcription factors that control those enzymes. Blood hormone levels also changed, with one stress hormone up and a thyroid hormone down.
Catalog record
| CREATOR | Przemysław J Danek, Renata Pukło, Władysława A Daniel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |